BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25644044)

  • 21. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate.
    Stanford CW; Kollipara R; Melookaran AM; Hall JC
    Cutis; 2014 Sep; 94(3):153-5. PubMed ID: 25279477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Oct; 155(4):846-7. PubMed ID: 16965444
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.
    Spertino J; Lopez-Ferrer A; Vilarrasa E; Puig L
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1514-21. PubMed ID: 25493314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of Von Zumbusch pustular psoriasis with infliximab.
    Trent JT; Kerdel FA
    J Cutan Med Surg; 2004; 8(4):224-8. PubMed ID: 16091999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile generalized pustular psoriasis with IL36RN mutation treated with short-term infliximab.
    Pan J; Qiu L; Xiao T; Chen HD
    Dermatol Ther; 2016 May; 29(3):164-7. PubMed ID: 26627198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efalizumab rebound response to a sequential therapy of infliximab followed by efalizumab.
    Brunasso AM; Delfino C; Massone C
    Dermatology; 2009; 218(1):73-4. PubMed ID: 18841002
    [No Abstract]   [Full Text] [Related]  

  • 28. Juvenile generalized pustular psoriasis.
    Kalla G; Goyal AM
    Pediatr Dermatol; 1996; 13(1):45-6. PubMed ID: 8919525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
    Yawalkar N; Hunger RE
    Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
    Dalaker M; Bonesrønning JH
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 32. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
    Umezawa Y; Mabuch T; Ozawa A
    Pediatr Dermatol; 2012; 29(2):206-8. PubMed ID: 22409471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of psoriasis: focus on clinic-based management with infliximab.
    de Eusebio E; Armario-Hita JC; de Miquel VA
    Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S5-16. PubMed ID: 24777571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term durability and dose escalation patterns in infliximab therapy for psoriasis.
    Luber AJ; Tsui CL; Heinecke GM; Lebwohl MG; Levitt JO
    J Am Acad Dermatol; 2014 Mar; 70(3):525-32. PubMed ID: 24388425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete reversion of anti-infliximab immunization by methotrexate combination in a patient with psoriasis.
    Vincent T; Best M; Plawecki M; Girard C
    J Dermatol; 2015 Oct; 42(10):1030-1. PubMed ID: 26119228
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.
    Farhangian ME; Feldman SR
    Am J Clin Dermatol; 2015 Aug; 16(4):285-294. PubMed ID: 25963062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recalcitrant, generalized pustular psoriasis: rapid and lasting therapeutic response to antitumour necrosis factor-alpha antibody (infliximab).
    Schmick K; Grabbe J
    Br J Dermatol; 2004 Feb; 150(2):367. PubMed ID: 14996114
    [No Abstract]   [Full Text] [Related]  

  • 39. A dramatic response to a single dose of infliximab as rescue therapy in acute generalized pustular psoriasis of von Zumbusch associated with a neutrophilic cholangitis.
    Chandran NS; Chong WS
    Australas J Dermatol; 2010 Feb; 51(1):29-31. PubMed ID: 20148838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy of biologics with traditional agents in psoriasis.
    Guenther LC
    Skin Therapy Lett; 2011 Jun; 16(6):1-3. PubMed ID: 21833461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.